Abstract
Naldemedine (Symproic(A (R))) is an orally active A mu-opioid receptor antagonist being developed by Shionogi & Co., Ltd. that has been approved i......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
